Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOral - PhysicianPharm

Relationship of Marrow Radiation Dose and Timing of Engraftment for Targeted Radioimmunotherapy with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] in Patients with Active Relapsed or Refractory Acute Myeloid Leukemia

Susan Passalaqua, Mona Natwa, Ming-Kai Chen, Robert Wagner, Wendell Yap, Landis Griffeth, Gregory Wiseman, Joyce Mhlanga, Richard Wahl, Norbert Avril, Robert Hellman, Dominick Lamonica, Manuela Matesan, Beth Chasen, Neil Hansen, Eugene Leung, Joseph Osborne, Jennifer Peterson, Yusuf Menda, Dinko Franceschi, Qing Liang, Vijay Reddy, Mark Berger and Neeta Pandit-Taskar
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 82;
Susan Passalaqua
1Banner MD Anderson Cancer Center Gilbert AZ United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mona Natwa
2Ohio State University Columbus OH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ming-Kai Chen
3Yale New Haven Hospital New Haven CT United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Wagner
4Loyola University Medical Center Maywood IL United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wendell Yap
5University of Kansas Medical Center Kansas City KS United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Landis Griffeth
6Baylor University Medical Center Dallas TX United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory Wiseman
7Mayo Clinic Rochester MN United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joyce Mhlanga
8Washington University St. Louis MO United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Wahl
8Washington University St. Louis MO United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norbert Avril
9University Hospitals Cleveland Medical Center Cleveland OH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Hellman
10Medical College of Wisconsin Milwaukee WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominick Lamonica
11Roswell Park Cancer Institute Buffalo NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuela Matesan
12University of Washington Medical Center Seattle WA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beth Chasen
13MD Anderson Cancer Center Houston TX United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil Hansen
14University of Nebraska Medical Center Omaha NE United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eugene Leung
15The Ottawa Hospital Ottawa ON Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Osborne
16Weill Cornell Medical College New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Peterson
17Mayo Clinic Jacksonville FL United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yusuf Menda
18University of Iowa Iowa City IA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dinko Franceschi
19Stony Brook University Hospital Stony Brook NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qing Liang
20Actinium Pharmaceuticals New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vijay Reddy
20Actinium Pharmaceuticals New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Berger
20Actinium Pharmaceuticals New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neeta Pandit-Taskar
21Memorial Sloan Kettering Cancer Center New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 62 no. supplement 1 82

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 18, 2021.

Copyright & Usage 
© 2021

Author Information

  1. Susan Passalaqua1,
  2. Mona Natwa2,
  3. Ming-Kai Chen3,
  4. Robert Wagner4,
  5. Wendell Yap5,
  6. Landis Griffeth6,
  7. Gregory Wiseman7,
  8. Joyce Mhlanga8,
  9. Richard Wahl8,
  10. Norbert Avril9,
  11. Robert Hellman10,
  12. Dominick Lamonica11,
  13. Manuela Matesan12,
  14. Beth Chasen13,
  15. Neil Hansen14,
  16. Eugene Leung15,
  17. Joseph Osborne16,
  18. Jennifer Peterson17,
  19. Yusuf Menda18,
  20. Dinko Franceschi19,
  21. Qing Liang20,
  22. Vijay Reddy20,
  23. Mark Berger20 and
  24. Neeta Pandit-Taskar21
  1. 1Banner MD Anderson Cancer Center Gilbert AZ United States
  2. 2Ohio State University Columbus OH United States
  3. 3Yale New Haven Hospital New Haven CT United States
  4. 4Loyola University Medical Center Maywood IL United States
  5. 5University of Kansas Medical Center Kansas City KS United States
  6. 6Baylor University Medical Center Dallas TX United States
  7. 7Mayo Clinic Rochester MN United States
  8. 8Washington University St. Louis MO United States
  9. 9University Hospitals Cleveland Medical Center Cleveland OH United States
  10. 10Medical College of Wisconsin Milwaukee WI United States
  11. 11Roswell Park Cancer Institute Buffalo NY United States
  12. 12University of Washington Medical Center Seattle WA United States
  13. 13MD Anderson Cancer Center Houston TX United States
  14. 14University of Nebraska Medical Center Omaha NE United States
  15. 15The Ottawa Hospital Ottawa ON Canada
  16. 16Weill Cornell Medical College New York NY United States
  17. 17Mayo Clinic Jacksonville FL United States
  18. 18University of Iowa Iowa City IA United States
  19. 19Stony Brook University Hospital Stony Brook NY United States
  20. 20Actinium Pharmaceuticals New York NY United States
  21. 21Memorial Sloan Kettering Cancer Center New York NY United States

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2021 to April 2025

AbstractFullPdf
May 20218700
Jun 202112700
Jul 202111500
Aug 20217100
Sep 20214700
Oct 20212800
Nov 20213100
Dec 20213800
Jan 20224300
Feb 20222900
Mar 20223900
Apr 20223200
May 20222100
Jun 20222300
Jul 20221900
Aug 20222000
Sep 2022800
Oct 20222400
Nov 20221700
Dec 20222100
Jan 20231900
Feb 20231100
Mar 20231300
Apr 2023700
May 2023800
Jun 20231100
Jul 20232900
Aug 20231500
Sep 20231700
Oct 20231600
Nov 20231000
Dec 20232200
Jan 2024600
Feb 20241400
Mar 20241200
Apr 20243400
May 20241600
Jun 20243900
Jul 20247900
Aug 20248000
Sep 20242000
Oct 20241300
Nov 20241500
Dec 20241500
Jan 20251100
Feb 20251200
Mar 20251500
Apr 20251300
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 62, Issue supplement 1
May 1, 2021
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Relationship of Marrow Radiation Dose and Timing of Engraftment for Targeted Radioimmunotherapy with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] in Patients with Active Relapsed or Refractory Acute Myeloid Leukemia
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Relationship of Marrow Radiation Dose and Timing of Engraftment for Targeted Radioimmunotherapy with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] in Patients with Active Relapsed or Refractory Acute Myeloid Leukemia
Susan Passalaqua, Mona Natwa, Ming-Kai Chen, Robert Wagner, Wendell Yap, Landis Griffeth, Gregory Wiseman, Joyce Mhlanga, Richard Wahl, Norbert Avril, Robert Hellman, Dominick Lamonica, Manuela Matesan, Beth Chasen, Neil Hansen, Eugene Leung, Joseph Osborne, Jennifer Peterson, Yusuf Menda, Dinko Franceschi, Qing Liang, Vijay Reddy, Mark Berger, Neeta Pandit-Taskar
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 82;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Relationship of Marrow Radiation Dose and Timing of Engraftment for Targeted Radioimmunotherapy with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] in Patients with Active Relapsed or Refractory Acute Myeloid Leukemia
Susan Passalaqua, Mona Natwa, Ming-Kai Chen, Robert Wagner, Wendell Yap, Landis Griffeth, Gregory Wiseman, Joyce Mhlanga, Richard Wahl, Norbert Avril, Robert Hellman, Dominick Lamonica, Manuela Matesan, Beth Chasen, Neil Hansen, Eugene Leung, Joseph Osborne, Jennifer Peterson, Yusuf Menda, Dinko Franceschi, Qing Liang, Vijay Reddy, Mark Berger, Neeta Pandit-Taskar
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 82;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns
  • Google Scholar

More in this TOC Section

Oral - PhysicianPharm

  • Stapled Peptide-based radiotheranostics agent targeting MDM2 suppresses p53-mutant tumor growth
  • 68Ga-PSMA PET/CT for response assessment and outcome prediction in metastatic prostate cancer undergoing taxane-based chemotherapy
  • High-throughput screening and bioinformatics analysis of 2,000 177Lu-PSMA and Radiotherapy + drug combinations
Show more Oral - PhysicianPharm

Cancer Radiopharmaceutical Therapy

  • Study evaluating the prognostic value of PET parameters after 177Lu-DOTATATE Peptide Receptor Therapy in NET patients
  • Prediction of absorbed dose by tumors and critical organs after Lu-177-DOTATATE therapy using pretherapeutic Ga-68-DOTATOC PET/CT
Show more Cancer Radiopharmaceutical Therapy

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire